These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 23368421)
1. Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia. Kako S; Kanamori H; Kobayashi N; Shigematsu A; Nannya Y; Nakamae M; Shigeno K; Suzukawa K; Takeuchi M; Tsuzuki M; Usuki K; Hatanaka K; Ogawa K; Mitani K; Nawa Y; Hatta Y; Mizuno I; Kanda Y Br J Haematol; 2013 Apr; 161(1):95-103. PubMed ID: 23368421 [TBL] [Abstract][Full Text] [Related]
2. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia]. Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen. Liew E; Atenafu EG; Schimmer AD; Yee KW; Schuh AC; Minden MD; Gupta V; Brandwein JM Leuk Res; 2012 Dec; 36(12):1517-20. PubMed ID: 22940259 [TBL] [Abstract][Full Text] [Related]
4. [Imatinib combined with modified hyper-CVAD/MA followed by allogeneic hematopoietic stem cell transplantation in CR1 as the front-line therapy for adult Ph(+) acute lymphoblastic leukemia]. Huang J; Zou DH; Fu MW; Li ZJ; Xu Y; Zhao YZ; Qi JY; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):673-8. PubMed ID: 22339825 [TBL] [Abstract][Full Text] [Related]
5. [Clinical study of Philadelphia chromosome-positive acute lymphoblastic leukemia]. Bao L; Jiang B; Huang XJ; Wang DB; Qiu JY; Lu XJ; Chen H; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):31-4. PubMed ID: 15946506 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission. Kaito S; Kurosawa S; Najima Y; Sakaida E; Shingai N; Fukuda T; Tachibana T; Uchida N; Ozawa Y; Sawa M; Nakazawa H; Ota S; Kato J; Nakamae H; Katayama Y; Eto T; Tanaka J; Kanda Y; Atsuta Y; Arai Y; Kako S; Transplant Cell Ther; 2022 Jun; 28(6):326.e1-326.e10. PubMed ID: 35306218 [TBL] [Abstract][Full Text] [Related]
7. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients]. Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562 [TBL] [Abstract][Full Text] [Related]
8. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia. Tang W; Wang L; Zhao WL; Chen YB; Shen ZX; Hu J Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment with imatinib-combined chemotherapy for relapsed Philadelphia-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation. IMAHASHI N; TOKUNAGA M; NISHIWAKI S; YANAGISAWA M; OZAWA Y; MIYAMURA K Rinsho Ketsueki; 2009 Nov; 50(11):1612-5. PubMed ID: 20009435 [TBL] [Abstract][Full Text] [Related]
10. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310 [TBL] [Abstract][Full Text] [Related]
11. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT. Spyridonidis A; Labopin M; Schmid C; Volin L; Yakoub-Agha I; Stadler M; Milpied N; Socie G; Browne P; Lenhoff S; Sanz MA; Aljurf M; Mohty M; Rocha V; Leukemia; 2012 Jun; 26(6):1211-7. PubMed ID: 22290066 [TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
13. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355 [TBL] [Abstract][Full Text] [Related]
14. Treatment of children with acute myeloid leukaemia who relapsed after allogeneic haematopoietic stem cell transplantation. Lee JW; Jang PS; Chung NG; Cho B; Kim HK Br J Haematol; 2013 Jan; 160(1):80-6. PubMed ID: 23106148 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994 [TBL] [Abstract][Full Text] [Related]
16. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA Br J Haematol; 2015 Feb; 168(3):395-404. PubMed ID: 25312094 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Fagioli F; Zecca M; Rognoni C; Lanino E; Balduzzi A; Berger M; Messina C; Favre C; Rabusin M; Lo Nigro L; Masetti R; Prete A; Locatelli F; Biol Blood Marrow Transplant; 2012 Jun; 18(6):852-60. PubMed ID: 22019726 [TBL] [Abstract][Full Text] [Related]
18. FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia. Specchia G; Pastore D; Carluccio P; Liso A; Mestice A; Rizzi R; Ciuffreda L; Pietrantuono G; Liso V Ann Hematol; 2005 Nov; 84(12):792-5. PubMed ID: 16047203 [TBL] [Abstract][Full Text] [Related]
19. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor. Chim CS; Lie AK; Liang R; Au WY; Kwong YL Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocol. Thyagu S; Minden MD; Gupta V; Yee KW; Schimmer AD; Schuh AC; Lipton JH; Messner HA; Xu W; Brandwein JM Br J Haematol; 2012 Aug; 158(4):506-14. PubMed ID: 22650180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]